Kykeon Analytics uses advanced analytical techniques to identify and characterize unknown psychoactive agents. These techniques include nuclear magnetic resonance, infrared spectroscopy, liquid chromatography, and mass spectrometry. The company creates spectral libraries to rapidly identify unknown samples, reducing the time and cost associated with manually identifying novel chemicals. These libraries are helpful for community workers and researchers.

Providing tools to help harm reduction associations, paramedics, and forensic teams identify unknown drug samples in the field. In field interventions we focus on the use of HPLC-UV, TLC and FTIR, while at our lab we also add other techniques such as MS and NMR. We aim to provide spectral data for novel, so-called designer drugs in order to help community workers identify these substances and save time in emergency situations.

As part of our harm reduction efforts, we continuously monitor developments in the ever-expanding market of newly emerging psychoactive compounds. This allows us to rapidly identify novel substances with suspected bioactivty, and to analytically characterize their digital profiles and include them in spectral databases. In addition, we also conduct test purchases of unscheduled new chemical entities in order to identify any possible adulterants in these samples and to contribute to the safety of the public by issuing early warnings about any toxic contaminants or fraudulent misrepresentations that our analyses reveal.